On private placement basis
Panacea Biotec announced that the Company had allotted 1,63,00,000 (One Crore Sixty Three Lac Only) 0.5%, Non-Convertible Cumulative Redeemable Preference Shares ('NCCRPS') of Rs.10 (Rupees Ten) each at par aggregating to Rs. 16.30 crore on private placement basis to the promotes of the Company in pursuance of Special Resolution passed by the shareholders in their Extra-Ordinary General Meeting held on 06 January 2015 at the Registered Office of the Company.Further, the aforesaid shares are issued in physical form and the Company does not intend to list the aforesaid shares on Stock exchange(s).
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app